Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioDGenesis for Symptomatic Lumbar Disc Degeneration
NCT02379689Unknown
- Sponsor
- Semmes-Murphey Foundation
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial in degenerative disc disease (DDD) comparing BioDGenesis with Placebo (2 arms). Primary endpoints: Visual Analog Scale for Low Back Pain at 52 weeks, Oswestry Disability Index at 52 weeks and 1 more. Status: unknown.
02
Drugs
BioDGenesis
03
Conditions
degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT02379689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379689.